All News

#ACR21 Abst#0801 Early remission at 6 mos is a predictor of long-term remission in patients w new onset RA ▶️ DAS28-CRP, SDAI, CDAI at 6mo predicted remission at 60 months https://t.co/vWy7EmseZp @Rheumnow https://t.co/HWJSjvFY8d

Links:

Eric Dein ericdeinmd ( View Tweet)
Good news for #COVID vaccine in #SLE. ✅doesn’t cause #lupus flares ➡️ no increase in APS. What about #SARS-CoV2 infection in SLE. Flares ↔️ stable but ⬆️APS Abs. from Hopkins cohort. Petri #ACRBest #ACR21 abst0858 @RheumNow https://t.co/ABx4C4lwvs
Janet Pope Janetbirdope ( View Tweet)
How can we better identify patients with #RA-ILD using #EHRs? Abs#0561: previously validated algorithms have clinical & research utility when applied to EHRs, esp when well-integrated with key info such as CT chest reports #ACR21 @RheumNow https://t.co/OU8BdwqHpc

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

ADACTA & MONARCH both showed IL6i monoRx > TNFi monoRx for RA in DBRCTs. What about in real-world data? Looking at CorEvitas, less so LDA: aOR 0.99 MCID in CDAI: 1.06 Even without MTX, both great drug classes for RA Equally so? #ACR21 ABST0834 @RheumNow https://t.co/6wvzVrXTW6 https://t.co/fYEktJhZuV

Links:

David Liew drdavidliew ( View Tweet)
#ACR21 A#0563 - Is FRAX score applicable for RA? 10 yr Olmsted County epi study: Yes ▶️ 76 osteoporotic fxs in RA pts, FRAX predicted 67 fx (SIR 1.13, not signif) ▶️ 21 observed hip fx, FRAX predicted 23.3 (SIR 0.9) ⭐️ No differences by ages/sex https://t.co/vWy7EmseZp @Rheumnow https://t.co/8BlzgQYqaV

Links:

Eric Dein ericdeinmd ( View Tweet)
6 year f/up study of sacroilitis in nr-AxSpA pts ⭐️~10% of pts progressed from nr-AxSpa to AS every 2 years Abs#907 #ACR21 @RheumNow https://t.co/kiWGmKhpWu

Links:

Robert B Chao, MD doctorRBC ( View Tweet)

Watch: What I'm Looking Forward to at #ACR21: Dr. Arthur Kavanaugh https://t.co/WygW1czwXn https://t.co/1qlZsFBd4Z

Links:

Dr. John Cush RheumNow ( View Tweet)
Guidance on self-efficacy (SE) in IA were published this yr- what factors influence this? 👉PROMs & treatment response determine long-term SE 👉This may help identify pts benefitting most from interventions to improve SE Abs#0795 #ACR21 @RheumNow https://t.co/dx28WgxNsE https://t.co/7uN6XctnQb

Links:

Mrinalini Dey DrMiniDey ( View Tweet)
#ACR21 Abst#0786. Fibroscan screening for liver injury in pts on MTX: ▶️No significant correlation between cumulative MTX dose and liver stiffness by fibroscan, even at high dose MTX. ⭐️Age, sex, waist circumference, BMI are risks @Rheumnow https://t.co/IhcNr9fhEh https://t.co/c7TUoGrNZ7

Links:

Eric Dein ericdeinmd ( View Tweet)
In Australia, there's free choice of originator vs biosimilar for etanercept. Real-world data shows exactly what you'd expect over >48 months - and sometimes it's what you expect that's exactly what you want to see... OPAL data #ACR21 0840 @RheumNow https://t.co/YJA2Cua9cw
David Liew drdavidliew ( View Tweet)
It was a pleasure to speak to Dr Bryant England about #multimorbidity in #rheumatoidarthritis with a focus on abstract #1924, to be presented at the #Epidemiology & #PublicHealth abstract session on Tuesday #ACR21: https://t.co/qHws6B3fFf Watch @RheumNow: https://t.co/OKM7WxIEpR

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

The opening quote of the day #ACR21 @RheumNow https://t.co/gow87jkvfJ
swethaann23 swethaann23 ( View Tweet)
#ACR21 Abst#0449: Ever wish you had a tool to help you predict which PsA pts will progress to radiographic damage? ➡️Proteomic approaches identified 103 candidate biomarker peptides related to 69 proteins that can potentially do so! @Rheumnow @uptoTate https://t.co/uUsZlBLTWC

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

There are no MRI imaging difference in axSpA with psoriasis, coliitis or iritis. 240 patients in the SASPIC study show psoriatic axSpA similar to axSpA associated with iritis or colitis. Supports the umbrella concept of axSpA @RheumNow #ACR21 Abst#0902 https://t.co/VKTUv22hEJ https://t.co/lOL82ceSn9

Links:

Dr. Antoni Chan synovialjoints ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.

Dr. John Cush RheumNow ( View Tweet)

#ACR21 Abst#0285 Calculated 10-yr CV risk ↑ w/in 1st yr of new RA dx in 53 Dutch pts: ➤43% had intermediate (I) or high (H) morbidity risk ➤76% had I or H mortality risk ◘ avg 57yo, 74%♀, 72% HTN, & 57% HLD *️⃣ Early CV risk assessment critical at RA diagnosis! @Rheumnow

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

#ACR21 Abst#0452 ⭐️Total Body PET/CT (TB-PET/CT) as a tool to identify subclinical PsA at the point of transition from psoriasis (PsO). ➡️Should all pts w/ new dx of PsO have a baseline TB-PET/CT to identify early PsA? #ACRBest @Rheumnow @uptoTate https://t.co/IuxVuJgFSd https://t.co/AIuH9CIucy

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
https://t.co/WPSMR0n0Ww
Bella Mehta bella_mehta ( View Tweet)
#ACR21 Abst#0182 Does tenderness in non-swollen joints of PsA or RA pts portend inflammation & radiographic damage? ⭐️NO, except in early PsA! ➡️Abnormal PDUS associated w/ radiographic progression vs tenderness otherwise #ACRBest @Rheumnow @uptoTate https://t.co/iB1E0SL45e https://t.co/3Q30LeCMH4

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Rx of knee OA. A step in the right direction? Many knee #OA studies show that exercise can help pain and maybe much more - strengthening, alignment, tone, maybe weight loss. Here is a trial - STEP-KOA to support it. #YearInReview #ACR21 @RheumNow https://t.co/rTZUeZuT1c

Links:

Janet Pope Janetbirdope ( View Tweet)

×